133099-09-9,
3-(S)-(1-cyano-1,1-diphenylmethyl)-1-tosylpyrrolidine,
(S)-3-(1-CYANO-1,1-DIPHENYLMETHYL)-1-TOSYLPYRROLIDINE,
(S)-2,2-diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile,
3-(S)-(+)-(1-cyano-1,1-diphenylmethyl)-1-tosylpyrrolidine,
Q-101009,
(S)-2,2-diphenyl-2-(1-tosyl-3-pyrrolidinyl)acetonitrile,
(3S)-1-Tosyl-alpha,alpha-diphenyl-3-pyrrolidineacetonitrile,
PubChem14793,
(s)-3-(1-cyano-1,1-diphenylmethyl)-1-tosylpyrrolid,
SCHEMBL3229344,
CTK8B4337,
KS-00001EBU,
DTXSID00628647,
(s)-3-(1-cyano-1,1-d,
XPQZNOFTICUMIN-HSZRJFAPSA-N,
CS-M0900,
6047AA,
ANW-44717,
CC0084,
MFCD11616859,
ZINC35653240,
AKOS015895850,
AC-8864,
AJ-92023,
AK-50669,
CS-13241,
AX8080931,
ST2404851,
TC-133462,
FT-0658048,
099C099,
I06-1426,
(s)-3-(1-cyano-1,1-diphenylmethyl)-1-tosyloxypyrrolidine,
3-( S)-(1-Cyano-1,1-diphenylMethyl)-1-tosylpyrrolidine,
3-(s)-(1-cayano-1,1-diphenylmethyl)-1-tosylpyrrolidine,
(S)-Diphenyl-[1-(toluene-4-sulfonyl)-pyrrolidin-3-yl]-acetonitrile,
(3s)- 1-[(4-methylphenyl)sulfonyl]-diphenyl-3-pyrrolidineacetonitrile,
(s)-3-(1-cyano-1,1-diphenylmethyl)-1-tosyloxypyrrolidine (darifenacin),
[(3S)-1-(4-Methylbenzene-1-sulfonyl)pyrrolidin-3-yl](diphenyl)acetonitrile,
3-Pyrrolidineacetonitrile, 1-[(4-methylphenyl)sulfonyl]-alpha,alpha-diphenyl-, (3S)-,
C25H24N2O2S,